Business Wire

VERIMATRIX

20.10.2021 17:47:06 CEST | Business Wire | Press release

Share
Verimatrix Announces Third Quarter 2021 Revenue

Regulatory News:

Verimatrix (Paris:VMX) today announced its revenue for the third quarter ended September 30, 2021.

Amedeo D’Angelo, Chairman and CEO, commented: “During the third quarter, we executed the implementation of our accelerated shift toward a subscription-based business, including through SaaS offerings. It included further developing the go-to-market strategy as well as reviewing organization and expenses to ensure we are spending and investing in alignment with our strategy. At the same time, we continue to expand our cloud-based offerings, as illustrated with the release of the Verimatrix Multi-DRM Core service earlier in 2021. Verimatrix is experiencing continuous growth of its SaaS business, as illustrated with the sequential growth of the ARR, even though products and offerings have not yet been changed to be subscription-only and “cloud first.” This growth should be further supported by new SaaS products going live throughout 2022. Additionally, the shift in our contract models toward full on-premises subscriptions starting beginning of 2022 will add to this positive trend and is expected to positively impact our ARR in 2022 and beyond.”

Amedeo D’Angelo continued, “Verimatrix reaffirms that this ongoing shift to a recurring revenue model, depsite how it mechanically affects recognition of revenues for the rest of 2021 and in 2022, stands as an opportunity to significantly expand the combined use of our core technologies and subscription-based services that offer unmatched security, speed, scalability and efficiency. It will put us, in the mid-term, on the right path toward an improved ability to generate recurring revenues and sound profitability.”

(en milliers de dollars) Q3-2021 Q3-2020 Q3 2021
vs. Q3 2020 
9 months
2021
 9 months
2020 
2021
vs. 2020 
 
Recurring revenue

6 149

8 244

-25%

18 489

       23 679

-22%

including subscriptions

1 426

1 116

28%

4 050

3 814

6%

including maintenance

4 723

7 128

-34%

14 439

       19 865

-27%

 
Non-recurring revenue

9 523

18 035

-47%

32 732

       46 770

-30%

 
Software revenue

15 672

26 279

-40%

51 221

       70 449

-27%

 
NFC patent licensing program

                  -  

                  -  

16 645

              -  

                 
Revenue

15 672

26 279

-40%

67 866

       70 449

-4%

Third quarter 2021 revenue

Verimatrix revenue was $15.7 million in the third quarter of 2021. While the revenue was significantly down year-on-year due to unfavorable base effect (strong one-time license revenues in Q3 2020) and as Covid-19 continues to impact BtoB spending and the ability to launch new infrastructure projects, it is up 1% compared with the second quarter of 2021.

Recurring revenue from subscription and maintenance fees were $6.1 million in the third quarter of 2021, representing 39% of reported revenue (compared with 31% a year ago).

Growth of subscription revenue (of SaaS and non-SaaS implementations) in the third quarter (which had temporarily decreased in the second quarter of 2021 as a consequence of some customers delaying their launch of services) was not sufficient to balance the expected decrease of maintenance revenue.

Recurring subscription revenue stood at $1.4 million in Q3 2021, compared with $1.1 million in Q3 2020 (+ 28%) and $1.2 million in Q2 2021 (+17%). In the third quarter of 2021, Verimatrix put in production five new SaaS implementations, bringing the number of completed implementations during the first nine months of 2021 to twelve.

As in the second quarter, maintenance revenue decreased year-over-year, while it was stabilized compared with the second quarter of 2021. The decrease in maintenance revenue was primarily a consequence of the decrease in new perpetual and term licenses that typically include renewable maintenance arrangements. Also, during the second half of 2020 and first quarter of 2021, Verimatrix had signed new term-license deals with existing customers converting them from a yearly maintenance-only relationship with perpetual license ownership to a multi-year license agreement delivering new versions of its conditional access and DRM software.The aim is to move them to a subscription-based contract at the renewal of their new licenses, thus supporting the Company’s strategy. This transition, which will ultimately increase ARR and continue to improve the Company’s revenue mix, caused maintenance revenue to decrease in 2021 vs. 2020.

ARR (Annual Recurring Revenue - see definition at the end of this press release) of subscription and SaaS was $6.5 million as of September 30, 2021, up 35% year-on-year and up 15% sequentially.

ARR of subscription/SaaS combined with maintenance grew to $25.6 million as of September 30, 2021, up 2% sequentially; it is nevertheless mechanically down year-over-year, due to the decrease of maintenance up to Q2 2021 and despite growth in subscription/SaaS ARR.

Non-recurring revenues from licenses, royalties and professional services was $9.5 million in the third quarter of 2021, globally flat compared with the second quarter of 2021 and down significantly vs. Q3 2020 when the company had generated strong one-time licences.

Royalties were $4.4 million in Q3 2021. These reoccurring revenues were stable compared with both Q3 2020 and Q2 2021.

9-month 2021 revenue

Revenue for the company in the first nine months of 2021 was $67.9 million, down 4% year-over-year. Nine-month 2021 revenue included $16.6 million revenue generated by the company’s NFC patent licensing program managed by France Brevets in Q2 2021, compared with nil in 2020.

Revenue for the sole core software business was $51.2 million in the first nine months of 2021, down 27% year-over-year. Recurring revenues from maintenance and subscription fee were $18.5 million (36% of core software business revenue). These recurring revenues were down year-over-year, with the growth of subscription revenue being offset by weaker maintenance revenue as explained above.

Non-recurring revenue from software licenses and non-recurring services was $32.7 million in the first nine months of 2021, down 30% year-over-year, as Covid-19 continues to impact BtoB spending and the ability to launch new infrastructure projects.

Liquidity

As of September 30, 2021, the company’s consolidated cash position was $39.8 million, up $6 million compared with June 30, 2021, mostly due to cash collection from customers. Net debt3 stood at $6.1 million at September 30, 2021, compared with $13.7 million at June 30, 2021 and $11.5 million at December 31, 2020. Verimatrix has a solid financial position to continue its ongoing transformation.

Governance and other information

Governance

During its meeting of October 19, 2021, the Board of directors appointed Mr. Jacopo Meneguzzo as an observer to the Board. In accordance with the company’s bylaws this nomination will then have to be ratified by the next general shareholders’ meeting. Mr. Meneguzzo is Head of Strategy at private equity firm Palladio Holding S.p.A.. Prior to joining Palladio Holding, Mr. Meneguzzo was a principal at the Boston Consulting Group and an investment banker at Citigroup. Palladio Holding S.p.A., which invests in listed and unlisted companies, has been a shareholder of Verimatrix since 2014 and currently holds 8.3% of the company’s capital.

Allocation of performance shares

Making use of a delegation from the shareholders’ general meeting of June 10, 2021, the Board of directors granted 1,020,000 free performance shares to certain employees and executives of the Company (including Mr. Amedeo D'Angelo, Chairman and Chief Executive Officer, for 500,000 performance shares). The definitive acquisition of the shares will be made on the double condition of presence in the Company on December 31, 2024 and the achievement of a demanding performance criterion in accordance with the strategy and ambitions of the Company (minimum level of ARR judged between December 31, 2021 and December 31, 2024); the grant may be accelerated in certain cases such as a change of control of the Company.

Business outlook

As presented in July 2021, the Company is engaged in an ongoing transformation of its operations to adapt to the new business and revenue models, focused on continuously growing recurring revenues and subscription-based business and developing the SaaS offering. At the same time, the Company continues to expand its cloud-based offering, as illustrated with the release of the Verimatrix Multi-DRM Core service earlier in 2021. Verimatrix is experiencing continuous growth of its SaaS business, as illustrated with the sequential growth of the ARR even though products and offerings have not yet been changed to be subscription-only and sales policy moved to “cloud first.” This growth should be further supported by new SaaS products going live throughout 2022. Additionally, the shift in contract models toward full on-premises subscriptions starting beginning of 2022 will add to this positive trend and is expected to positively impact the ARR in 2022 and beyond.

In that context, the Company confirms the objectives communicated in July 2021:

  • 2021 revenue of $90 million
  • Improvement of the quality of the revenue mix in the mid term with 70% recurring revenues in 2024 (compared with 36% today)

Financial calendar

  • Fiscal year 2021 results: March 10, 2022 (after market close)

About Verimatrix

Verimatrix (Euronext Paris: VMX) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure everything from premium movies and live streaming sports, to sensitive financial and healthcare data, to mission-critical mobile applications. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit www.verimatrix.com .

Forward-looking statements

This press release contains certain forward-looking statements concerning Verimatrix. Although Verimatrix believes its expectations to be based on reasonable assumptions, they do not constitute guarantees of future performance. Accordingly, the Company’s actual results may differ materially from those anticipated in these forward-looking statements owing to a number of risks and uncertainties. For a more detailed description of these risks and uncertainties, please refer to the "Risk factors " section of the 2020 universal registration document filed with the French financial market authority (the Autorité des marchés financiers – the “AMF”) on April 30, 2021, available on investors.verimatrix.com .

Supplementary non-IFRS financial information

This press release contains certain financial measures and performance indicators are not defined under IFRS. They do not constitute accounting elements used to measure the company’s financial performance. They should be considered as additional information, which cannot replace any other strictly accounting-based operating or financial performance measure, as presented in the company’s consolidated financial statements and their related notes. The company uses these indicators because it believes they are useful measures of its recurring operating performance and its operating cash flows. Although they are widely used by companies operating in the same industry around the world, these indicators are not necessarily directly comparable to those of other companies, which may have defined or calculated their indicators differently than the company, even though they use similar terms.

Annual Recurring Revenue , or ARR , corresponds annualized value of all recurring revenues from current contracts at the time of measurement. ARR includes all contract types that are recurring in nature, such as maintenance & support, SaaS and non-SaaS subscriptions, and for which revenue is currently being recognized. The ARR is a rolling number that accumulates over time whereas the Total Contract Value (or TCV) metric also used by the Company, is typically used to measure (new or incremental) sales bookings within a period. The Company computes an ARR for SaaS and non-SaaS subscriptions and another combining subscriptions and maintenance.

Net debt reconciliation

(in thousands of US$, unaudited)   September 30,
2021
June 30,
2021
December 31,
2020
     
Cash and cash equivalents

39 843

32 010

48 608

Private loan note due 2026, at fair value

(28 076)

(28 076)

(42 491)

Convertible bonds due 2022 (OCEANE), at fair value

(17 811)

(17 594)

(17 542)

Other loans

(56)

(56)

(117)

 
Net cash/(debt)  

(6 100)

(13 716)

(11 542)

       
Financial lease commitments under IFRS16

(11 271)

(11 353)

(13 773)

       
Net cash/(debt) including IFRS 16  

(17 371)

(25 069)

(25 315)

1 Recurring revenues comprise maintenance and support fees and subscription fees (of SaaS and non-SaaS implementations); they exclude revenue from royalties.
2 For definition, see “Supplementary non-IFRS financial information” at the end of the press release.
3 Net debt is defined as cash on hand, cash equivalents and short-term investments, less bank overdrafts, financial debt (excluding obligations under IFRS 16 for finance leases), bank loans, private loan ($29 million unitranche bullet private loan maturing in February 2026), and the debt component of the “OCEANE” convertible bonds due June 2022 (see reconciliation with IFRS at the end of this press release).

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye